HSL Mobile App
Dr Reddys Laboratories Ltd
22 Jul 2026 12:00 AM
Dr Reddy`s Laboratories consolidated net profit declines 68.67% in the June 2026 quarter,
Net profit of Dr Reddy`s Laboratories declined 68.67% to Rs 444.30 crore in the quarter ended June 2026 as against Rs 1418.10 crore during the previous quarter ended June 2025. Sales declined 5.56% to Rs 8070.50 crore in the quarter ended June 2026 as against Rs 8545.20 crore during the previous quarter ended June 2025. ParticularsQuarter EndedJun. 2026Jun. 2025% Var. Sales8070.508545.20 -6 OPM %10.6525.44 - PBDT1089.902381.10 -54 PBT553.301905.00 -71 NP444.301418.10 -69 Powered by Capital Market - Live News
Dr Reddys Laboratories Ltd
22 Jul 2026 12:00 AM
Dr Reddy`s appoints Dr. Sridevi Khambhampaty as Global Head of Biologics,
The board of Dr Reddys Laboratories at its meeting held on 22 July 2026 has appointed Dr. Sridevi Khambhampaty as Global Head of Biologics and Senior Management Personnel of the Company effective 22 July 2026.
Dr Reddys Laboratories Ltd
23 Jun 2026 12:00 AM
Dr Reddys Laboratories to table results,
Dr Reddys Laboratories will hold a meeting of the Board of Directors of the Company on 22 July 2026.
Dr Reddys Laboratories Ltd
19 Jun 2026 12:00 AM
Dr Reddys Laboratories allots 6,730 equity shares under ESOP,
Dr Reddys Laboratories has allotted 6,730 equity shares under ESOP on 19 June 2026. Post allotment, the paid up equity share capital has increased to 83,46,76,800 equity shares of Re 1 each.
Dr Reddys Laboratories Ltd
05 Jun 2026 12:00 AM
Dr Reddys Laboratories allots 12,100 equity shares under ESOS,
Dr Reddys Laboratories has allotted 12,100 equity shares under ESOS on 05 June 2026. With this allotment, the paid up equity share capital has increased to Rs 83,46,70,070 /-.
Subscribe for our
newsletter
newsletter
